PR Newswire
BRIDGEWATER, N.J., Nov. 24, 2020
BRIDGEWATER, N.J. , Nov. 24, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the virtual Evercore ISI 3 rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 8:00 a.m. ET .
The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the company's website at www.insmed.com . The webcast will be archived for a period of 30 days following the conclusion of the live event.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States and the European Union to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey , with a growing footprint across Europe and in Japan . For more information, visit www.insmed.com .
Contact:
Investors:
Argot Partners
Laura Perry or Heather Savelle
(212) 600-1902
Insmed@argotpartners.com
Media:
Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download multimedia: http://www.prnewswire.com/news-releases/insmed-to-present-at-the-evercore-isi-3rd-annual-healthconx-conference-301178239.html
SOURCE Insmed Incorporated
